320 related articles for article (PubMed ID: 32715763)
1. Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury.
Zhao Y; Zeng H; Liu B; He X; Chen JX
Am J Physiol Renal Physiol; 2020 Aug; 319(2):F345-F357. PubMed ID: 32715763
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
Han WQ; Zhu Q; Hu J; Li PL; Zhang F; Li N
Biochim Biophys Acta; 2013 Jun; 1833(6):1454-62. PubMed ID: 23466866
[TBL] [Abstract][Full Text] [Related]
3. Ablation of endothelial prolyl hydroxylase domain protein-2 promotes renal vascular remodelling and fibrosis in mice.
Wang S; Zeng H; Chen ST; Zhou L; Xie XJ; He X; Tao YK; Tuo QH; Deng C; Liao DF; Chen JX
J Cell Mol Med; 2017 Sep; 21(9):1967-1978. PubMed ID: 28266128
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor prolyl-hydroxylase 2 senses high-salt intake to increase hypoxia inducible factor 1alpha levels in the renal medulla.
Wang Z; Zhu Q; Xia M; Li PL; Hinton SJ; Li N
Hypertension; 2010 May; 55(5):1129-36. PubMed ID: 20308610
[TBL] [Abstract][Full Text] [Related]
5. Regulatory Role of Endothelial PHD2 in the Hepatic Steatosis.
Zhou LY; Zeng H; Wang S; Chen JX
Cell Physiol Biochem; 2018; 48(3):1003-1011. PubMed ID: 30036883
[TBL] [Abstract][Full Text] [Related]
6. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
Jiao X; Xu X; Fang Y; Zhang H; Liang M; Teng J; Ding X
Nephrology (Carlton); 2017 May; 22(5):366-373. PubMed ID: 27030384
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1α contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells.
Wang Z; Tang L; Zhu Q; Yi F; Zhang F; Li PL; Li N
Kidney Int; 2011 Feb; 79(3):300-10. PubMed ID: 20881940
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Endothelial PHD2 Suppresses Post-Ischemic Kidney Inflammation through Hypoxia-Inducible Factor-1.
Rajendran G; Schonfeld MP; Tiwari R; Huang S; Torosyan R; Fields T; Park J; Susztak K; Kapitsinou PP
J Am Soc Nephrol; 2020 Mar; 31(3):501-516. PubMed ID: 31996410
[TBL] [Abstract][Full Text] [Related]
9. Silencing of HIF prolyl-hydroxylase 2 gene in the renal medulla attenuates salt-sensitive hypertension in Dahl S rats.
Zhu Q; Hu J; Han WQ; Zhang F; Li PL; Wang Z; Li N
Am J Hypertens; 2014 Jan; 27(1):107-13. PubMed ID: 24190904
[TBL] [Abstract][Full Text] [Related]
10. Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation.
Takeda K; Fong GH
Hypertension; 2007 Jan; 49(1):178-84. PubMed ID: 17101841
[TBL] [Abstract][Full Text] [Related]
11. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice.
Chen JX; Stinnett A
Diabetes; 2008 Dec; 57(12):3335-43. PubMed ID: 18835934
[TBL] [Abstract][Full Text] [Related]
12. The hypoxia-inducible factor-α prolyl hydroxylase inhibitor FG4592 ameliorates renal fibrosis by inducing the H3K9 demethylase JMJD1A.
Ike T; Doi S; Nakashima A; Sasaki K; Ishiuchi N; Asano T; Masaki T
Am J Physiol Renal Physiol; 2022 Nov; 323(5):F539-F552. PubMed ID: 36074918
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia Upregulates Estrogen Receptor β in Pulmonary Artery Endothelial Cells in a HIF-1α-Dependent Manner.
Frump AL; Selej M; Wood JA; Albrecht M; Yakubov B; Petrache I; Lahm T
Am J Respir Cell Mol Biol; 2018 Jul; 59(1):114-126. PubMed ID: 29394091
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
[TBL] [Abstract][Full Text] [Related]
15. Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling.
Wang S; Zeng H; Xie XJ; Tao YK; He X; Roman RJ; Aschner JL; Chen JX
Oncotarget; 2016 Sep; 7(37):58848-58861. PubMed ID: 27613846
[TBL] [Abstract][Full Text] [Related]
16. Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia.
Kunze R; Zhou W; Veltkamp R; Wielockx B; Breier G; Marti HH
Stroke; 2012 Oct; 43(10):2748-56. PubMed ID: 22933585
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
18. Deletion of phd2 in myeloid lineage attenuates hypertensive cardiovascular remodeling.
Ikeda J; Ichiki T; Matsuura H; Inoue E; Kishimoto J; Watanabe A; Sankoda C; Kitamoto S; Tokunou T; Takeda K; Fong GH; Sunagawa K
J Am Heart Assoc; 2013 Jun; 2(3):e000178. PubMed ID: 23778187
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of HIF prolyl-hydoxylase-2 transgene in the renal medulla induced a salt sensitive hypertension.
Zhu Q; Liu M; Han WQ; Li PL; Wang Z; Li N
J Cell Mol Med; 2012 Nov; 16(11):2701-7. PubMed ID: 22686466
[TBL] [Abstract][Full Text] [Related]
20. Regulation of hypoxia inducible factor/prolyl hydroxylase binding domain proteins 1 by PPARα and high salt diet.
Ozurumba E; Mathew O; Ranganna K; Choi M; Oyekan A
J Basic Clin Physiol Pharmacol; 2018 Mar; 29(2):165-173. PubMed ID: 29500923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
